[Form 4] Hinge Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE)November 18, 2025, Bessemer Venture Partners X L.P. converted 2,119,271 shares of Class B Common Stock into 2,119,271 shares of Class A Common Stock, and Bessemer Venture Partners X Institutional L.P. converted 1,989,436 Class B shares into 1,989,436 Class A shares.

On the same date, BVP X sold 373,955 shares of Hinge Health Class A Common Stock and BVP X Institutional sold 351,045 Class A shares. The reporting person, a partner at Bessemer Venture Partners, notes only an indirect, passive economic interest in these Bessemer funds and expressly disclaims beneficial ownership beyond any pecuniary interest.

11/20/2025 - 06:54 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Robinson Elliott

(Last) (First) (Middle)

C/O BESSEMER VENTURE PARTNERS

1865 PALMER AVENUE, SUITE 104

(Street)

LARCHMONT NY 10538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	11/18/2025		C		0	A	(1)	0	I	See footnote(1)(3)
Class A Common Stock	11/18/2025		S		0(2)	D	$0	0	I	See footnote(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	(1)	11/18/2025		C			0	(1)	(1)	Class A Common Stock	0	(1)	0	I	See footnote(3)

Explanation of Responses:

1. On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.

2. BVP X sold 373,955 shares of Class A Common Stock of the Issuer, and BVP X Inst. sold 351,045 shares of Class A Common Stock of the Issuer.

3. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

	/s/ Augie Wilkinson, Attorney-in-Fact	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Hinge Health (HNGE) disclose in this Form 4?

The Form 4 reports that on November 18, 2025, Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P. converted Class B Common Stock of Hinge Health, Inc. into Class A Common Stock and also sold Class A shares.

How many Hinge Health Class B shares were converted to Class A by the Bessemer funds?

Bessemer Venture Partners X L.P. converted 2,119,271 Class B Common shares into the same number of Class A shares, and Bessemer Venture Partners X Institutional L.P. converted 1,989,436 Class B shares into 1,989,436 Class A shares.

How many Hinge Health (HNGE) Class A shares were sold by the Bessemer funds?

According to the Form 4, BVP X sold 373,955 Class A Common shares of Hinge Health, and BVP X Inst. sold 351,045 Class A Common shares.

What is the reporting person’s relationship to Hinge Health (HNGE) and the Bessemer funds?

The reporting person is identified as a director and 10% owner of Hinge Health and is a partner at Bessemer Venture Partners, with an indirect, passive economic interest in the Bessemer funds that hold Hinge Health shares.

Does the reporting person claim full beneficial ownership of the Hinge Health shares held by the Bessemer funds?

No. The reporting person disclaims beneficial ownership of securities held by the Bessemer funds, except to the extent of any pecuniary interest arising from indirect interests in those funds.

Why were Hinge Health Class B shares convertible into Class A shares?

The Class B Common Stock of Hinge Health was convertible into Class A Common Stock upon certain events described in the company’s amended and restated certificate of incorporation, which governed the terms of conversion.